Ted Cohen
Ted Cohen
Department of Epidemiology of Infectious Diseases, Yale School of Public Health
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Transmission dynamics and control of severe acute respiratory syndrome
M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ...
Science 300 (5627), 1966-1970, 2003
13872003
Negative controls: a tool for detecting confounding and bias in observational studies
M Lipsitch, ET Tchetgen, T Cohen
Epidemiology (Cambridge, Mass.) 21 (3), 383, 2010
5452010
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
T Cohen, M Murray
Nature medicine 10 (10), 1117-1121, 2004
3522004
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
3412013
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
HE Jenkins, AW Tolman, CM Yuen, JB Parr, S Keshavjee, ...
The Lancet 383 (9928), 1572-1579, 2014
2842014
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
HH Lin, M Murray, T Cohen, C Colijn, M Ezzati
The Lancet 372 (9648), 1473-1483, 2008
2802008
The effect of drug resistance on the fitness of Mycobacterium tuberculosis
T Cohen, B Sommers, M Murray
The Lancet infectious diseases 3 (1), 13-21, 2003
2252003
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
NA Menzies, T Cohen, HH Lin, M Murray, JA Salomon
PLoS Med 9 (11), e1001347, 2012
2232012
Antiviral resistance and the control of pandemic influenza
M Lipsitch, T Cohen, M Murray, BR Levin
PLoS Med 4 (1), e15, 2007
2192007
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
1962014
Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants
JD Goldhaber-Fiebert, CY Jeon, T Cohen, MB Murray
International journal of epidemiology 40 (2), 417-428, 2011
1792011
Origin and proliferation of multiple-drug resistance in bacterial pathogens
HH Chang, T Cohen, YH Grad, WP Hanage, TF O'Brien, M Lipsitch
Microbiology and Molecular Biology Reviews 79 (1), 101-116, 2015
1632015
Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control
T Cohen, PD van Helden, D Wilson, C Colijn, MM McLaughlin, I Abubakar, ...
Clinical microbiology reviews 25 (4), 708-719, 2012
1622012
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study
T Cohen, M Murray, K Wallengren, GG Alvarez, EY Samuel, D Wilson
PLoS Med 7 (6), e1000296, 2010
1542010
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations
T Cohen, M Lipsitch, RP Walensky, M Murray
Proceedings of the National Academy of Sciences 103 (18), 7042-7047, 2006
1512006
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
AL Manson, KA Cohen, T Abeel, CA Desjardins, DT Armstrong, ...
Nature genetics 49 (3), 395, 2017
1462017
Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission
T Cohen, C Colijn, B Finklea, M Murray
Journal of the Royal Society Interface 4 (14), 523-531, 2007
1372007
The transmission of Mycobacterium tuberculosis in high burden settings
TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ...
The Lancet infectious diseases 16 (2), 227-238, 2016
1272016
No coexistence for free: neutral null models for multistrain pathogens
M Lipsitch, C Colijn, T Cohen, WP Hanage, C Fraser
Epidemics 1 (1), 2-13, 2009
1222009
Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment
SS Shin, S Keshavjee, IY Gelmanova, S Atwood, MF Franke, ...
American journal of respiratory and critical care medicine 182 (3), 426-432, 2010
1092010
The system can't perform the operation now. Try again later.
Articles 1–20